There are a number of areas in which the American Medical Association has worked positively and consistently for many years in the public interest. One such area is in the field of drugs. Through its Council on Drugs, the AMA has exercised leadership and sought to protect the public in a way that I think is not very well known to physicians, let alone the public.
More than ten years ago when some of us became concerned about what seemed to be an increasing incidence of aplastic anemia, it was agreed that means should be found to explore the possible cause or causes of this condition. The AMA promptly took action in this direction and gave support by forming the Committee on Blood Dyscrasias under the auspices of the Council on Drugs. That committee began by collecting information about various drug-associated blood dyscrasias that were occurring throughout the country. In
Wintrobe MM. The Problem of Adverse Drug Reactions. JAMA. 1966;196(5):404–405. doi:10.1001/jama.1966.03100180072022
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: